Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/03/19 → 28/02/22 |
Collaborative partners
- Rīga Stradiņš University
- Latvian Biomedical Research and Study Centre (lead)
Understanding the biology of the minimal residual disease after targeted therapy of BRAF mutant melanoma
- Pjanova, Dace (Project leader)
- Kreishmane, Madara (Expert)